The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Cooper Laurence James Neil since 1.
This trader's CIK number is 1641506.
At the time of last reporting, Cooper Laurence James Neil was the President and CEO of Ziopharm Oncology Inc. (stock ticker symbol ZIOP).
Also see all insider trading activities at Ziopharm Oncology Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2021 | ZIOP | 0 | $0 | 105,693 | $286,428 | 0 | $0 |
2019 | ZIOP | 0 | $0 | 110,694 | $540,186 | 44,642 | $99,998 |
2019 | ZIOP | 0 | $0 | 110,694 | $540,186 | 44,642 | $99,998 |
2017 | ZIOP | 6,440 | $30,139 | 0 | $0 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2021-01-04 | ZIOP | Sale | 105,693 | 2.71 | 286,428 |
2019-12-30 | ZIOP | Sale | 110,694 | 4.88 | 540,186 |
2019-12-27 | ZIOP | Option Ex | 44,642 | 2.24 | 99,998 |
2017-11-08 | ZIOP | Buy | 6,440 | 4.68 | 30,139 |
2019-12-30 | ZIOP | Sale | 110,694 | 4.88 | 540,186 |
2019-12-27 | ZIOP | Option Ex | 44,642 | 2.24 | 99,998 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cooper Laurence James Neil (President and CEO of Ziopharm Oncology Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.